Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07123090What this trial is testingSasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell Carcinoma+3 more Stephanie Berg 25
Testing effectiveness (Phase 2)Looking for participantsNCT06940518What this trial is testingPhase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forIvonescimabClear Cell Renal Carcinoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03075423What this trial is testingRandomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCWho this might be right forMetastatic Renal Cell Carcinoma Goethe University 316
Testing effectiveness (Phase 2)Looking for participantsNCT07594106What this trial is testingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC) Regeneron Pharmaceuticals 265
Testing effectiveness (Phase 2)UnknownNCT00293501What this trial is testingTinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer University of Vermont 35
Large-scale testing (Phase 3)Study completedNCT02883153What this trial is testingZirconium-89-girentuximab PET/CT Imaging in Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT04704219What this trial is testingPembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)UnknownNCT00025103What this trial is testingChemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyWho this might be right forKidney Cancer Children's Cancer and Leukaemia Group 75
Testing effectiveness (Phase 2)WithdrawnNCT00293527What this trial is testingInterferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal CarcinomaWho this might be right forRenal Cancer Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706What this trial is testingPembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 1,854
Not applicableUnknownNCT04946266What this trial is testingProspective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney CancersWho this might be right forKidney Cancer University Hospital, Strasbourg, France 260
Very early researchLooking for participantsNCT07067905What this trial is testingClinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma and Glioblastoma Chinese PLA General Hospital 15
Testing effectiveness (Phase 2)UnknownNCT03475953What this trial is testingA Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsWho this might be right forColorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more Institut Bergonié 747
Not applicableStudy completedNCT00900536What this trial is testingDNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCEWho this might be right forKidney Cancer Medical Research Council
Testing effectiveness (Phase 2)Study completedNCT01499121What this trial is testingStudy of Efficacy and Safety of Sunitinib Given on an Individualized ScheduleWho this might be right forClear Cell, Metastatic Renal Cell Carcinoma Sunnybrook Health Sciences Centre 117
Testing effectiveness (Phase 2)Study completedNCT02019576What this trial is testingStereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With SunitinibWho this might be right forClear Cell Metastatic Renal Cell Carcinoma Sunnybrook Health Sciences Centre 38
Testing effectiveness (Phase 2)Ended earlyNCT04300140What this trial is testingSafety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Aravive, Inc. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256223What this trial is testingA Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver SpreadWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Liver Metastasis Fudan University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972What this trial is testingIparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyWho this might be right forRCC, Renal Cell Cancer Tianjin Medical University Cancer Institute and Hospital 36